Method and composition for the treatment of imflammatory conditions using thiosulphinic acid derivatives

Abstract

The invention concerns thiosulphinic acid derivatives, medicaments containing these compounds and their use in medicine. It has been found that thiosulphinic acid derivatives display outstanding inflammation-inhibiting properties. The compounds prove to be especially advantageous in the treatment of PAF-induced inflammatory processes of the bronchial area.

Description

Claims

1. A method for the treatment of inflammation comprising administering to patients with inflammation a pharmaceutically effective amount of a thiosulphinic acid compound of the formula (I) ##STR3## wherein R.sub.1 and R.sub.2, which can be the same or different, comprise an unsubstituted or substituted C.sub.1 -C.sub.6 alkyl, C.sub.6 -C.sub.14 aryl, aralkyl having a C.sub.6 -C.sub.14 aryl moiety and a C.sub.1 -C.sub.4 alkylene moiety or a C.sub.6 -C.sub.10 cycloaliphatic in a pharmaceutically acceptable carrier with the proviso that

when R.sub.1 is CH.sub.3, ethyl, propyl, butyl, amyl, allyl, benzyl, .beta.-carboxythyl, cyclohexyl, m-carboxyphenyl, p-aminophenyl, .delta.-diethylaminopropyl or .alpha.-dimethyl-beta-amino-beta carboxyethyl then R.sub.2 cannot be the same group, and when R.sub.1 is ethane R.sub.2 cannot be tert-butyl.

2. The method of claim 1 further comprising administering to patients having an inflammation the compound of formula I wherein R.sub.1 or R.sub.2 is an unsubstituted or substituted C.sub.1 -C.sub.6 alkyl, phenyl, naphthyl, anthryl, benzyl, phenethyl, cyclohexyl or cyclopentyl group and wherein the substituents thereon are hydroxyl, formyl, carboxyl, amino, cyano or halogen and wherein further substituents on the phenyl, naphthyl, benzyl, phenethyl or anthryl group are C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 alkoxy, C.sub.1 -C.sub.6 alkylthio, aryloxy, aryl or aralkyl.

3. The method of claim 1 or 2 further comprising administering to patients having an inflammation the compound of formula I wherein when R.sub.1 is the same as R.sub.2 and is methyl R.sub.2 is propyl and when R.sub.1 is propyl R.sub.2 is methyl.

4. The method of claim 1 or 2 further comprising administering to patients having an inflammation the compound of formula I wherein R.sub.1 is methyl or 1-propenyl and R.sub.2 is 1-propenyl or methyl.

5. The method of claim 1 or 2 further comprising administering to patients having an inflammation the compound of Formula I wherein R.sub.1 is propyl or 1-propenyl and R.sub.2 is 1-propenyl or propyl.

6. The method of claim 1 or 2 further comprising administering to patients having an inflammation the compound of Formula I wherein R.sub.1 or R.sub.2 is unsubstituted or substituted phenyl.

7. The method of claim 1 or 2 further comprising administering to patients having an inflammation one or more of a compound selected from the group consisting of ##STR4##

8. The method of claim 7 further comprising administering to patients having bronchial asthma.

9. The method of claim 7 further comprising administering to patients having an allergic disease comprising allergic inflammation or allergic reactions.

10. The method of claim 7 wherein the compound acts as a lipoxygenase or cyclooxygenase inhibitor.

11. The method of claim 7 further comprising administering to patients having a PAF-induced inflammatory disease.

12. The method of claim 7 further comprising administering to a patient having rheumatism.

13. The method of claim 12 further comprising administering to a patient having polyarthritis.